AOSPINE MASTERS SERIES. VOL. 2: PRIMARY SPINAL TUMORS

Chapter 1: Pediatric Otolaryngology-I-lead and Neck Surgery
Chapter 2: Pediatric Malignancies
Chapter 3: Rhinology, Allergy, and Immunology
Chapter 4: General Otolaryngology
Chapter 5: Laryngology
Chapter 6: Otology, Neurotology, and Lateral Skull Base Surgery
Chapter 7: Head and Neck Surgical Oncology
Chapter 8: Cutaneous Malignancies
Chapter 9: Facial Plastic and Reconstructive Surgery
Chapter 10: Facial Trauma
Chapter 11: Salivary Gland Disorders
Chapter 12: Endocrine Disorders
Chapter 13: Odontogenic Disorders

This second volume in the AOSpine Masters Series balances critical appraisal of current evidence in spine oncology with the opinions of experienced spine surgeons to create a unique clinical reference for spine oncology surgeons. The book provides expert guidance to help clinicians make the right treatment decisions and provide the best care for their patients. The chapters have been written and researched by key leaders in spine oncology and range from general evaluation, staging, and decision making principles to histology-specific oncologic patient management.

Key Features:
- Editors are internationally-recognized authorities on the treatment of primary spine tumors
- Synthesizes the best available evidence and consensus expert advice on primary spine tumors, leading to optimal clinical recommendations
- Each chapter includes clinical pearls, tips on complication avoidance, and top 5 must-read references

The AOSpine Masters Series, a co-publication of Thieme and the AOSpine Foundation, addresses current clinical issues whereby international masters of spine share their expertise and recommendations on a particular topic. The goal of the series is to contribute to an evolving, dynamic model of an evidence-based medicine approach to spine care.

All neurosurgeons, orthopedic surgeons, neuro-oncologists, and orthopedic oncologists specializing in spine, along with residents and fellows in these areas, will find this book to be an excellent resource that they will often refer to in their treatment of patients with primary tumors of the spine.